Literature DB >> 11087888

A new treatment for postherpetic neuralgia.

C P Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11087888     DOI： 10.1056/NEJM200011233432110

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study.

Authors:  Christian Lampl; Christine Schweiger; Bernhard Haider; Anita Lechner
Journal:  J Neurol       Date:  2010-03-11       Impact factor: 4.849

2.  Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.

Authors:  Lynn R Webster; Marvin Tark; Richard Rauck; Jeffrey K Tobias; Geertrui F Vanhove
Journal:  BMC Neurol       Date:  2010-10-11       Impact factor: 2.474

Review 3.  Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia.

Authors:  Pamela S Davies; Bradley S Galer
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Herpes zoster infection and postherpetic neuralgia.

Authors:  R B Tenser
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 6.030

5.  Intravenous patient-controlled analgesia hydromorphone combined with pregabalin for the treatment of postherpetic neuralgia: a multicenter, randomized controlled study.

Authors:  Ying Huang; Chenjie Xu; Tao Zeng; Zhongming Li; Yanzhi Xia; Gaojian Tao; Tong Zhu; Lijuan Lu; Jing Li; Taiyuan Huang; Hongbo Huai; Benxiang Ning; Chao Ma; Xinxing Wang; Yuhua Chang; Peng Mao; Jian Lin
Journal:  Korean J Pain       Date:  2021-04-01

6.  A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain.

Authors:  Cristina Nativi; Roberta Gualdani; Elisa Dragoni; Lorenzo Di Cesare Mannelli; Silvia Sostegni; Martina Norcini; Gabriele Gabrielli; Giancarlo la Marca; Barbara Richichi; Oscar Francesconi; Maria Rosa Moncelli; Carla Ghelardini; Stefano Roelens
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.